Method for removing viruses and leukocytes from blood using a surface comprising hydroxyl and polyethylene glycol groups
It is intended to provide a method whereby a virus and leukocytes can be simultaneously eliminated from virus-containing blood and platelets can be recovered at a high yield, and a material and an apparatus therefor. A water-soluble carrier having surface which is capable of capturing a virus and leukocytes in blood but allows the permeation of platelets therethrough is brought into contact with virus-containing blood. Thus the virus and leukocytes can be simultaneously removed from the blood while platelets can be recovered at a high yield.
1. A method for selectively and simultaneously removing free and/or protein-bound viruses and leukocytes from blood, comprising:
bringing virus-containing blood into contact with a material for selectively removing viruses and leukocytes, said material for selectively removing viruses and leukocytes comprising a water-insoluble carrier having a surface which captures viruses and leukocytes in blood and allows platelets in blood to permeate therethrough, said surface comprising at least a hydroxyl group and a polyethylene glycol group.
2. The method according to claim 1 , wherein the virus-containing blood is brought into contact with the material for selectively removing viruses and leukocytes by using an adsorption method and/or a filtration method.
3. The method according to claim 1 , further comprising:
mixing the virus-containing blood with an anticoagulant, and
bringing the virus-containing blood mixed with the anticoagulant into contact with the material for selectively removing viruses and leukocytes at a flow rate of 10 ml/min to 100 ml/min.
4. The method according to claim 1 , wherein the leukocytes to be removed include at least lymphocytes.
5. The method according to claim 1 , wherein the leukocytes to be removed include at least autoreactive T cells.
6. The method according to claim 1 , wherein the material for selectively removing viruses and leukocytes has a capability of increasing the concentration of an activated complement C3a in blood by five times or more after being brought into contact with the blood.
7. The method according to claim 1 , wherein the water-insoluble carrier is fibrous.
8. The method according to claim 7 , wherein the carrier for removing leukocytes is a nonwoven fabric.
9. The method according to claim 1 , wherein the viruses are hepatitis C viruses.